BioSpace News Archive

Medicago expects to enroll 180 healthy adult participants Preliminary safety and immunogenicity results are expected in October 2020 Dynavax is providing CpG 1018, the adjuvant contained in its U.S. FDA-approved adult hepatitis B vaccine, to enhance the immune response of Medicago’s COVID-19 vaccine candidate

To stem the spread of the COVID-19 virus in the midst of a spike in the number of cases and hospitalizations, the State of Arizona recently awarded Phoenix-based concierge phlebotomy services pioneer Vestra Labs a contract to provide virus testing at 148 skilled nursing facilities throughout the state.

Sanofi Canada is pleased to announce a positive recommendation from the Institut national d’excellence en santé et en services sociaux (INESSS) for DUPIXENT® (dupilumab) for Quebec residents aged 12 to 17 years with moderate-to-severe atopic dermatitis whose disease is not adequately managed with current therapy and when specific conditions are met

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma”, stock code: 600196.SH; 02196.HK) announces that its subsidiary Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd. (“Fosun Pharmaceutical Industrial”) has received the acceptance notice of clinical trial application for the licensed COVID-19 vaccine product candid

Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of single-port robotic surgical technologies, today issued an update letter to its shareholders.

Industry Thought-Leader and Veteran Strategist to Lead Further Expansion of Global Regulatory & Quality Services

Vytelle and GrowSafe Systems, Ltd. announced today the combining of their companies with the aim of accelerating genetic advances in bovine biotechnology.

Surgical care is one of the most essential courses of actions required to effectively manage a variety of health conditions including obstructed labor, injuries, malignancy, cardiovascular disease and infections.

Dr. Reddy’s Laboratories Ltd. announced the launch of Over-the-Counter Nicotine Polacrilex Lozenges, 2 mg and 4 mg, the store brand version of Nicorette® Lozenges in the U.S. market.

Histogen Inc., a regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body, announced completion of patient enrollment ahead of schedule in its Phase 1b/2a clinical trial of HST 001, designed to assess the safety, tolerability and indicators of efficacy of HST 001 for the treatment of androgenic alopecia in men.